psalexa
Order Summary
Biosimilars Market By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Technology (mAb, rDNA, Bioassays, Nuclear Magnetic Resonance, Electrophoresis), Indication (Oncology, Rheumatology, Blood-Related Disorders, Auto-Immune Diseases, Chronic Diseases, Infectious Diseases, Growth Hormone Deficiency), Route of Administration (Intravenous, Subcutaneous, Intranasal), Geographical Outlook – Trends Analysis and Growth Forecast to 2024
License Type
Single User License
Price
USD 4900
Total amount to be paid
USD 4900
Billing Information
Select a payment mode
  • Secure Payment
  • Secured by PayPal
Clicking Proceed to Secure Checkout means that you agree to the P&S Intelligence's terms & conditions

We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. More info X